Home » Newsletters » BioWorld

BioWorld

April 7, 1992

View Archived Issues

FDA APPROVES ABBOTT MONOCLONAL ASSAY

TRANSKARYOTIC LICENSES FACTOR IX

COLLABORATION TO BUILD ON CANCER DISCOVERY

GYNEX TO TEST OXANDRIN FOR AIDS PATIENTS

COMBINATION ARTHRITIS TREATMENT

HUMAN CLOTTING FACTOR FROM TRANSGENIC PIGS

ORGANOGENESIS FINDS PARTNER IN JAPAN

ENZO WINS PATENT CHALLENGE IN EUROPE

MERCK EXTENDS IMMULOGIC AGREEMENT

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...